Bioresorbable Polymers Market to Reach USD 867.2 million by 2029, Growing at a CAGR of 11.6% — MarketsandMarkets™

Delray Beach, FL, Aug. 17, 2026 (GLOBE NEWSWIRE) -- The global Bioresorbable Polymers Market is projected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6% during the forecast period. Growth is driven by the increasing number of surgical interventions, rising demand for biocompatible medical devices, and growing adoption of bioresorbable materials in orthopedic devices and drug delivery applications. Advances in polymer technology, electrospinning, and 3D printing are further creating opportunities for patient-specific and minimally invasive medical solutions.

Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235258717

Key Market Highlights

• Market Size (2024): USD 500.0 Million
• Projected Market Value (2029): USD 867.2 Million
• CAGR (2024–2029): 11.6%
• Largest Region: North America
• Fastest-Growing Region: Asia Pacific
• Largest Type: Polylactic-co-glycolic Acid (PLGA)
• Fastest-Growing Type: Polylactic-co-glycolic Acid (PLGA)
• Largest Application: Orthopedic Devices
• Fastest-Growing Application: Drug Delivery
• Key Players: Corbion, Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM Biomedical, Ashland Global Holdings, Zeus Company, Seqens, Reva Medical, and Poly-Med Incorporated.

Why This Market Matters

Bioresorbable polymers can naturally degrade inside the body, reducing the need for secondary removal procedures. Their use in orthopedic implants, sutures, drug delivery systems, and tissue engineering supports the shift toward patient-centric healthcare solutions.

Market Overview

The market is expanding as healthcare providers and medical device manufacturers seek biocompatible materials with controlled degradation and improved performance. PLA, PGA, PLGA, and PCL are increasingly used across advanced medical applications.

Analyst Perspective

PLGA is expected to remain a key growth area because its degradation rate can be engineered by adjusting its composition. Meanwhile, electrospinning and 3D printing are opening new opportunities in tissue engineering and personalized medical implants.

Speak to Our Analyst — Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235258717

Segment Analysis

• By Type: PLGA is projected to be the fastest-growing segment, supported by its biocompatibility, biodegradability, and controlled degradation characteristics.
• By Application: Drug delivery is expected to register the fastest growth due to increasing demand for controlled and sustained drug-release systems.
• Orthopedic Devices: Remain a major application, driven by demand for implants that provide temporary support while naturally degrading.

Regional Analysis

North America represents a major market for bioresorbable polymers, supported by demand for orthopedic devices and advanced drug delivery technologies. Asia Pacific is expected to register the highest growth, driven by increasing healthcare expenditure, expanding pharmaceutical and medical device industries, and a growing geriatric population. India is identified as the fastest-growing market in the region.

Key Industry Trends

• Rising adoption of bioresorbable orthopedic implants
• Increasing demand for controlled drug delivery systems
• Growing use of 3D printing and electrospinning
• Development of patient-specific medical devices
• Increasing focus on biocompatibility and controlled degradation
• Expansion of advanced healthcare infrastructure in Asia Pacific

Competitive Landscape

Leading companies are focusing on product launches, acquisitions, and capacity expansions to strengthen their positions. Key players include Corbion, Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM Biomedical, Ashland Global Holdings, Zeus Company, Seqens, Reva Medical, and Poly-Med Incorporated.

Related Reports

Bioplastics & Biopolymers Market

Fluoropolymers Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Report Code: CH 4342 | Published: 25 Nov 2024 | Report Pages: 221 | Market Data Tables: 257 | Figures: 58